{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T08:51:37Z","timestamp":1781686297478,"version":"3.54.5"},"reference-count":33,"publisher":"Norwegian Medical Association","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"DOI":"10.4045\/tidsskr.20.0676","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T04:14:58Z","timestamp":1601525698000},"source":"Crossref","is-referenced-by-count":0,"title":["Status of COVID-19 vaccine development"],"prefix":"10.4045","volume":"140","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0256-3603","authenticated-orcid":false,"given":"Arne Michael","family":"Taxt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnveig","family":"Gr\u00f8deland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8289-8410","authenticated-orcid":false,"given":"Andreas","family":"Lind","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","published-online":{"date-parts":[[2020,9,9]]},"reference":[{"key":"ref=1","unstructured":"World Health Organization. WHO announces COVID-19 outbreak a pandemic. https:\/\/www.euro.who.int\/en\/health-topics\/health-emergencies\/coronavirus-covid-19\/news\/news\/2020\/3\/who-announces-covid-19-outbreak-a-pandemic Lest 2.9.2020."},{"key":"ref=2","unstructured":"Zhou\u00a0P, Yang\u00a0XL, Wang\u00a0XG et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579: 270\u20133. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=32015507&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1038%2Fs41586-020-2012-7"},{"key":"ref=3","unstructured":"Folkh\u00e4lsomyndigheten. F\u00f6rekomsten av covid-19 i Sverige 21\u201324 april och 25\u201328 maj 2020. https:\/\/www.folkhalsomyndigheten.se\/publicerat-material\/publikationsarkiv\/f\/forekomsten-av-covid-19-i-sverige-21-24-april-och-25-28-maj-2020\/ Lest 2.9.2020."},{"key":"ref=4","unstructured":"Poll\u00e1n\u00a0M, P\u00e9rez-G\u00f3mez\u00a0B, Pastor-Barriuso\u00a0R et al. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study. Lancet 2020; 396: 535\u201344. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=32645347&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2FS0140-6736(20)31483-5"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"Grifoni\u00a0A, Weiskopf\u00a0D, Ramirez\u00a0SI et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 2020; 181: 1489\u20131501.e15. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=32473127&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.cell.2020.05.015","DOI":"10.1016\/j.cell.2020.05.015"},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"Shereen\u00a0MA, Khan\u00a0S, Kazmi\u00a0A et al. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. J Adv Res 2020; 24: 91\u20138. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=32257431&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.jare.2020.03.005","DOI":"10.1016\/j.jare.2020.03.005"},{"key":"ref=7","unstructured":"Fehr\u00a0AR, Perlman\u00a0S. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol 2015; 1282: 1\u201323. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=25720466&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1007%2F978-1-4939-2438-7_1"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"Christian\u00a0MD, Poutanen\u00a0SM, Loutfy\u00a0MR et al. Severe acute respiratory syndrome. Clin Infect Dis 2004; 38: 1420\u20137. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15156481&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1086%2F420743","DOI":"10.1086\/420743"},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"Chafekar\u00a0A, Fielding\u00a0BC. MERS-CoV: Understanding the Latest Human Coronavirus Threat. Viruses 2018; 10: 93. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=29495250&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.3390%2Fv10020093","DOI":"10.3390\/v10020093"},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"Wu\u00a0A, Peng\u00a0Y, Huang\u00a0B et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe 2020; 27: 325\u20138. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=32035028&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.chom.2020.02.001","DOI":"10.1016\/j.chom.2020.02.001"},{"key":"ref=11","unstructured":"Wang\u00a0Y, Anirudhan\u00a0V, Du\u00a0R et al. RNA-dependent RNA polymerase of SARS-CoV-2 as a therapeutic target. J Med Virol 2020; jmv.26264. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=32633831&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002%2Fjmv.26264"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"Hoffmann\u00a0M, Kleine-Weber\u00a0H, Schroeder\u00a0S et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2020; 181: 271\u2013280.e8. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=32142651&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.cell.2020.02.052","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"Hofmann\u00a0H, Pyrc\u00a0K, van der Hoek\u00a0L et al. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc Natl Acad Sci U S A 2005; 102: 7988\u201393. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15897467&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1073%2Fpnas.0409465102","DOI":"10.1073\/pnas.0409465102"},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"Yan\u00a0R, Zhang\u00a0Y, Li\u00a0Y et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 2020; 367: 1444\u20138. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=32132184&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1126%2Fscience.abb2762","DOI":"10.1126\/science.abb2762"},{"key":"ref=15","unstructured":"To\u00a0KK, Tsang\u00a0OT, Leung\u00a0WS et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis 2020; 20: 565\u201374. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=32213337&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2FS1473-3099(20)30196-1"},{"key":"ref=16","doi-asserted-by":"crossref","unstructured":"Sun\u00a0B, Feng\u00a0Y, Mo\u00a0X et al. Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients. Emerg Microbes Infect 2020; 9: 940\u20138. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=32357808&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1080%2F22221751.2020.1762515","DOI":"10.1080\/22221751.2020.1762515"},{"key":"ref=17","doi-asserted-by":"crossref","unstructured":"Peng\u00a0H, Yang\u00a0LT, Wang\u00a0LY et al. Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients. Virology 2006; 351: 466\u201375. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16690096&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.virol.2006.03.036","DOI":"10.1016\/j.virol.2006.03.036"},{"key":"ref=18","unstructured":"World Health Organization. Draft landscape of COVID-19 candidate vaccines. https:\/\/www.who.int\/publications\/m\/item\/draft-landscape-of-covid-19-candidate-vaccines Lest 28.8.2020."},{"key":"ref=19","doi-asserted-by":"crossref","unstructured":"Farrington\u00a0CP, Miller\u00a0E. Vaccine trials. Mol Biotechnol 2001; 17: 43\u201358. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11280930&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1385%2FMB%3A17%3A1%3A43","DOI":"10.1385\/MB:17:1:43"},{"key":"ref=20","doi-asserted-by":"crossref","unstructured":"Folegatti\u00a0PM, Bittaye\u00a0M, Flaxman\u00a0A et al. Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial. Lancet Infect Dis 2020; 20: 816\u201326. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=32325038&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2FS1473-3099(20)30160-2","DOI":"10.1016\/S1473-3099(20)30160-2"},{"key":"ref=21","unstructured":"van Doremalen\u00a0N, Lambe\u00a0T, Spencer\u00a0A et al. ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques. bioRxiv 2020; 2020.05.13.093195. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=32511340&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1101%2F2020.05.13.093195"},{"key":"ref=22","unstructured":"Folegatti\u00a0PM, Ewer\u00a0KJ, Aley\u00a0PK et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1\/2, single-blind, randomised controlled trial. Lancet 2020; 396: 467\u201378. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=32702298&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2FS0140-6736(20)31604-4"},{"key":"ref=23","doi-asserted-by":"crossref","unstructured":"Wu\u00a0L, Zhang\u00a0Z, Gao\u00a0H et al. Open-label phase I clinical trial of Ad5-EBOV in Africans in China. Hum Vaccin Immunother 2017; 13: 2078\u201385. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=28708962&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1080%2F21645515.2017.1342021","DOI":"10.1080\/21645515.2017.1342021"},{"key":"ref=24","unstructured":"Zhu\u00a0FC, Li\u00a0YH, Guan\u00a0XH et al. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. Lancet 2020; 395: 1845\u201354. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=32450106&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2FS0140-6736(20)31208-3"},{"key":"ref=25","doi-asserted-by":"crossref","unstructured":"Sekaly\u00a0RP. The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development? J Exp Med 2008; 205: 7\u201312. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18195078&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1084%2Fjem.20072681","DOI":"10.1084\/jem.20072681"},{"key":"ref=26","unstructured":"Jackson\u00a0LA, Anderson\u00a0EJ, Rouphael\u00a0NG et al. An mRNA vaccine against SARS-CoV-2 \u2014 Preliminary report. N Engl J Med 2020; 383: NEJMoa2022483. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=32663912&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1056%2FNEJMoa2022483"},{"key":"ref=27","doi-asserted-by":"crossref","unstructured":"Gao\u00a0Q, Bao\u00a0L, Mao\u00a0H et al. Development of an inactivated vaccine candidate for SARS-CoV-2. Science 2020; 369: 77\u201381. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=32376603&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1126%2Fscience.abc1932","DOI":"10.1126\/science.abc1932"},{"key":"ref=28","unstructured":"Heaton\u00a0PM. The Covid-19 vaccine-development multiverse. N Engl J Med 2020; 383: NEJMe2025111. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=32663910&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1056%2FNEJMe2025111"},{"key":"ref=29","doi-asserted-by":"crossref","unstructured":"Acosta\u00a0PL, Caballero\u00a0MT, Polack\u00a0FP. Brief history and characterization of enhanced respiratory syncytial virus disease. Clin Vaccine Immunol 2015; 23: 189\u201395. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=26677198&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1128%2FCVI.00609-15","DOI":"10.1128\/CVI.00609-15"},{"key":"ref=30","doi-asserted-by":"crossref","unstructured":"Huisman\u00a0W, Martina\u00a0BEE, Rimmelzwaan\u00a0GF et al. Vaccine-induced enhancement of viral infections. Vaccine 2009; 27: 505\u201312. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19022319&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.vaccine.2008.10.087","DOI":"10.1016\/j.vaccine.2008.10.087"},{"key":"ref=31","doi-asserted-by":"crossref","unstructured":"Weiss\u00a0RC, Scott\u00a0FW. Antibody-mediated enhancement of disease in feline infectious peritonitis: comparisons with dengue hemorrhagic fever. Comp Immunol Microbiol Infect Dis 1981; 4: 175\u201389. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6754243&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2F0147-9571(81)90003-5","DOI":"10.1016\/0147-9571(81)90003-5"},{"key":"ref=32","unstructured":"Coish\u00a0JM, MacNeil\u00a0AJ. Out of the frying pan and into the fire? Due diligence warranted for ADE in COVID-19. Microbes Infect 2020; S1286-4579(20)30124-6. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=32590062&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.micinf.2020.06.006"},{"key":"ref=33","doi-asserted-by":"crossref","unstructured":"Ulrich\u00a0H, Pillat\u00a0MM, T\u00e1rnok\u00a0A. Dengue Fever, COVID-19 (SARS-CoV-2), and Antibody-Dependent Enhancement (ADE): A Perspective. Cytometry A 2020; 97: 662\u20137. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=32506725&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002%2Fcyto.a.24047","DOI":"10.1002\/cyto.a.24047"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":["Status for vaksineutvikling mot covid-19"],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T07:52:54Z","timestamp":1781682774000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2020\/09\/kronikk\/status-vaksineutvikling-mot-covid-19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,9]]},"references-count":33,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2020,9,29]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.20.0676","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,9]]}}}